Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus

Bone Turnover Markers in Patients with Type 2 Diabetes and Their Correlation with Glycosylated Haemoglobin Levels

(2013) I Capoglu et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone

(2011) M. Marenzana et al.   ARTHRITIS AND RHEUMATISM

Serum concentrations of osteocalcin, procollagen type 1 N-terminal propeptide and beta-CrossLaps in obese subjects with varying degrees of glucose tolerance

(2011) P. Iglesias et al.   CLINICAL ENDOCRINOLOGY

Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover

(2011) Antoon H van Lierop et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus

(2011) Antonia García-Martín et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway

(2011) Asiri R. Wijenayaka et al.   PLoS One

Liver Fat Content in Type 2 Diabetes: Relationship With Hepatic Perfusion and Substrate Metabolism

(2010) L. J. Rijzewijk et al.   DIABETES

Novel insights into the relationship between diabetes and osteoporosis

(2010) Francisco J. A. de Paula et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Thiazolidinediones induce osteocyte apoptosis and increase sclerostin expression

(2010) G. Mabilleau et al.   DIABETIC MEDICINE

Thiazolidinediones and fracture risk in patients with Type 2 diabetes

(2010) D. J. Betteridge   DIABETIC MEDICINE

Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls

(2010) A H van Lierop et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Insulin receptor expression in bone

(2010) D. M. Thomas et al.   JOURNAL OF BONE AND MINERAL RESEARCH

A naturally occurring isoform inhibits parathyroid hormone receptor trafficking and signaling

(2010) Verónica Alonso et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

(2010) Desmond Padhi et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Regulation of circulating sclerostin levels by sex steroids in women and in men

(2010) Ulrike IL Mödder et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Thiazolidinediones and Fractures: Evidence from Translating Research into Action for Diabetes

(2010) Dori Bilik et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus

(2010) Zeina A. Habib et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss

(2010) Agostino Gaudio et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Mechanisms of impaired bone strength in type 1 and 2 diabetes

(2010) D. Merlotti et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Thiazolidinediones and Fractures in Men and Women

(2009) Colin R. Dormuth et al.   ARCHIVES OF INTERNAL MEDICINE

Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate Metabolism Without Affecting Cardiac Triglyceride Accumulation and High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Diabetes Mellitus

(2009) Rutger W. van der Meer et al.   CIRCULATION

A Cohort Study of Thiazolidinediones and Fractures in Older Adults with Diabetes

(2009) Daniel H. Solomon et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes

(2009) Bernard Zinman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Risk of Fractures Associated with Thiazolidinediones: A Self-controlled Case-Series Study

(2009) Ian J. Douglas et al.   PLOS MEDICINE

Use of Thiazolidinediones and Fracture Risk

(2008) Christian Meier et al.   ARCHIVES OF INTERNAL MEDICINE

Diabetes and Its Complications and Their Relationship with Risk of Fractures in Type 1 and 2 Diabetes

(2008) Peter Vestergaard et al.   CALCIFIED TISSUE INTERNATIONAL

Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)

(2008) S. E. Kahn et al.   DIABETES CARE

Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength

(2008) Xiaodong Li et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Plasma Osteocalcin Is Inversely Related to Fat Mass and Plasma Glucose in Elderly Swedish Men

(2008) Jenny M Kindblom et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Diabetic Patients Have an Increased Risk of Vertebral Fractures Independent of BMD or Diabetic Complications

(2008) Masahiro Yamamoto et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice

(2008) Mathieu Ferron et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA